Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
QURE
#2169
uniQure N.V.
15.6
3
-9.76%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-9.76%
Monthly Change
-34.90%
6 month change
-1.01%
Cambio anual
+33.02%
Cierres anteriores
17.3
2
Open
15.6
3
Bid
Ask
Low
15.6
3
High
15.6
3
Volumen
137
Markets
Acciones
Atención Sanitaria
QURE
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
44.99 M
46.46 M
46.98 M
47.84 M
54.08 M
—
Valuation ratios
Enterprise value
1.38 B
407.26 M
798.09 M
90.16 M
796.07 M
4.71 B
Price to earnings ratio
—
2.95
-8.06
-1.07
-3.59
-22.97
Price to sales ratio
—
1.85
9.59
20.85
31.68
304.34
Price to cash flow ratio
—
3.37
7.04
2.26
4.7
31.94
Price to book ratio
—
1.63
2.14
1.59
127.24
149.22
Enterprise value to EBITDA ratio
-8.26
1.64
-4.11
-0.28
54.59
-31.41
Profitability ratios
Return on assets %
0.37
0.41
0.18
0.37
0.43
0.05
Return on equity %
0.51
0.55
0.27
1.49
35.48
2.37
Return on invested capital %
-537.78
796.56
-212.61
-426.75
-377.81
-373.73
Gross margin %
92.27
95.23
98.82
99.59
95.33
352.35
Operating margin %
-334.34
59.28
-134.44
-1 785.46
-679.58
-5 600.29
EBITDA margin %
-445.82
47.52
-182.45
-2 064.32
53.77
-1 009.24
Net margin %
333.27
62.9
119.07
1 947.09
883.35
1 295.26
Liquidity ratios
Quick ratio
—
—
6.19
8.68
—
—
Current ratio
9.47
17.09
6.28
8.85
9.74
38.84
Inventory turnover
—
—
0.18
0.01
—
—
Asset turnover
0.1
0.91
0.14
0.02
0.04
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.1
0.12
0.15
0.12
0.09
0.32
Long term debt to total equity ratio
0.15
0.17
0.22
0.49
-7.6
-18.79
Per share metrics
Operating cash flow per share
—
6.15
-3.1
-3.06
-3.76
-2.94
EBIT per share
—
5.19
-4.33
-7.31
-0.13
-1.09
EBITDA per share
—
5.32
-4.16
-6.86
0.3
-0.93
Total debt per share
—
—
—
—
—
—
Cash per share
—
11.88
7.55
12.96
7.56
34.6
Net current asset value per share
—
13.41
10.2
13.67
8.02
36.53
Tangible book value per share
—
10.79
8.38
2.53
-2.06
-1.69
Working capital per share
—
12.63
8.58
12.13
7.2
32.47
Book value per share
—
12.72
10.19
4.36
-0.14
4.52
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
Noticias
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)
Resultados de uniQure en foco mientras se acerca decisión regulatoria sobre AMT-130
Resultados de uniQure en foco mientras se define ruta regulatoria de AMT-130
uniQure earnings in focus as AMT-130 regulatory path looms
Stifel comenta las acciones de uniQure tras declaraciones del comisionado de la FDA
Stifel comenta acciones de uniQure tras declaraciones del comisionado de FDA
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Applied Materials, Broadcom among market cap stock movers on Thursday
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Las acciones de UniQure se desploman tras declaraciones de la FDA sobre ensayo de terapia génica
Acciones de UniQure caen tras comentarios de la FDA sobre terapia génica